These sources consist of legitimate science or are evidence based through the use of credible scientific sourcing. Legitimate science follows the scientific method, is unbiased, and does not use emotional words. These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.
- Overall, we rate GEN a Pro-Science source based on the use of peer-reviewed science as sources for news reporting.
Bias Rating: PRO-SCIENCE
Factual Reporting: HIGH
Press Freedom Rating: MOSTLY FREE
Media Type: Website
Traffic/Popularity: Medium Traffic
MBFC Credibility Rating: HIGH CREDIBILITY
Founded in 1980 by Mary Ann Liebert, Genetic Engineering and Biotechnology News is a publication reporting on the fields of gene editing, drug discovery and industry news. According to their about page “GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities.”
Funded by / Ownership
GEN is owned and published by Mary Ann Liebert, Inc., and revenue is derived from advertising and subscription fees.
Analysis / Bias
In review, GEN publishes news that is sourced from peer-reviewed publications such as this: Cancer-Killing T Cells Subdued, Kept “Stemmy,” by Potassium. Gen also covers industry news such as this: Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration. There is generally little bias, and all information is sourced properly.
Failed Fact Checks
- None in the Last 5 years
Overall, we rate GEN a Pro-Science source based on the use of peer-reviewed science as sources for news reporting. (D. Van Zandt 3/30/2019) Updated (11/18/2022)
Last Updated on November 18, 2022 by Media Bias Fact Check